Hatcher J. Ballard

Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas

Guido Ghilardi, Elise A. Chong, Jakub Svoboda et al. · Annals of Oncology · 2022 · 89 citations · Full text

Lymphoid Neoplasia, Large B-cell Lymphomas, Medicine +7

Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer

Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi et al. · Cancer Discovery · 2022 · 86 citations · Full text

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Reid W. Merryman, Luca Castagna, Laura Giordano et al. · Leukemia · 2021 · 77 citations

Lymphoid Neoplasia, Transplantation, Medicine +7

Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas

Jakub Svoboda, Steven M. Bair, Daniel J. Landsburg et al. · Haematologica · 2020 · 51 citations · Full text

Immunology, Pathology, Metronomic Chemotherapy +18

Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma

Reid W. Merryman, Robert Redd, Taiga Nishihori et al. · Blood Advances · 2021 · 45 citations · Full text

Cell Therapy, Anti-pd-1 Therapy, Relapsed/refractory Hodgkin Lymphoma +19